stocks
stocks · page 2
- Markets & Stocks
Argent BioPharma Sees 74% Sales Decline, Cantourage Enjoys 62% Sales Increase, & Organigram Progresses With BAT Investment
Argent BioPharma [stock_market_widget type=”chart” template=”line” assets=”RGT.L” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Argent BioPharma (formerly MGC Pharmaceuticals) has released its latest preliminary financial figures for the year to June 30, 2024, revealing a sharp drop in revenues but a reigning in of net losses compared to the previous year.
- Uncategorized
Rescheduling Delay Sends Cannabis Stocks Into Tailspin
News that the US Drug Enforcement Administration (DEA) is set to host a public administrative hearing on cannabis rescheduling has immediately impacted cannabis stocks.
- Uncategorized
Voyager Life Seeks Exit From Cannabis Market, IMC Pushes Through 6:1 Share Consolidation, & European Cannabis Firms Target US Listings
Voyager Life [stock_market_widget type=”chart” template=”line” assets=”VOY.AQ” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Aquis-listed CBD brand Voyager Life is the latest cannabis firm to be eyeing an exit from the sector, a move that has proven popular with its investors.
- Markets & Stocks
Chill Brands Ousted Directors Transferred $400k to Personal Accounts While CEO Absent, & Germany’s CanG Changes Boost Cannovum’s Stock
Chill Brands [stock_market_widget type=”chart” template=”line” assets=”CHLL.L” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Chill Brands’ ongoing boardroom debacle took another dramatic turn this week following revelations that its ousted directors acted ‘to defraud the business’ while its CEO was temporarily suspended.
- Uncategorized
Cannabis Stocks Up Nearly 20% in Q3 Following Rescheduling Recommendation
Last week’s news that the US could potentially reschedule cannabis from to Schedule III has seen global cannabis stocks skyrocket.
- Markets & Stocks
Hellenic Dynamics Sees Stocks Slide On News It Will No Longer Target EU-GMP, DeepVerge Downsizes Core Operations, & Celadon Publishes 2022 Figures
Hellenic Dynamics [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”HELD.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Hellenic Dynamics has seen its stock drop nearly 40% this week following an announcement that it would no longer be pursuing EU GMP (Good Manufacturing Practice) certification for its facility.
- Markets & Stocks
German Announcement Hits Stocks, Ananda Shares Skyrocket, & Futura Medical Launches Flagship Product In The UK
Last week’s announcement from the German Health Minister Dr Karl Lauterbach has seen the stock in a number of companies with significant operations in Germany take a hit.
- Markets & Stocks
European Cannabis Stocks Review: Intercure Sues Better To Recover Loans As Acquisition Falls Through, Yooma Pulls Out Of Japan & More From Chill Brands
Intercure Israel’s largest cannabis company, Intercure, saw its stock fall around 10% this week as it became involved in a legal dispute with Cann Pharmaceuticals, which trades as Better.
- Companies
European Cannabis Stocks See Hundreds Of Millions Wiped Off Value In 2022, 3 Board Members Leave Love Hemp, & More From SEED Innovations
European Cannabis Stocks 2022 Cannabis companies across Europe have had an extremely difficult year on the markets, with more than £1bn wiped off their collective market value.
- Markets & Stocks
European Cannabis Stocks Review: InterCure Up 10% Amid More Record Results, Stenocare Secures New Funding, & More From Goodbody Health
InterCure InterCure saw its stock jump nearly 10% after releasing its third quarter financial results on Tuesday, November 15.
- Adult-Use
The States Reform Act is a long shot, but we’ll take it
There is more bad news from Quebec-based HEXO, who has announced that it is shuttering three production facilities — two in Ontario, one in Nova Scotia — two of which were only acquired in the last year or so.
- Cannabis Daily News
Jefferies is betting on these U.S. weed stocks
New York-based investment banking company Jefferies Group is initiating coverage of seven U.S. pot stocks — Curaleaf, Green Thumb, Trulieve, Cresco, Columbia Care, TerrAscend and Ayr Strategies — and upgraded them all to a “buy” rating, reports BNN Bloomberg.
